Mark Grigoryan, Pediatric Infectious Diseases Fellow at Yerevan State Medical University, shared on LinkedIn:

“I am happy to share our recent article ‘A Case Series of Hemophagocytic Lymphohistiocytosis: An Atypical Presentation of Visceral Leishmaniasis’ published in Cureus.

Part of a collaboration with Dr. Saten Hovhannisyan and Dr. Violeta Manukyan, this case series explores the importance of early diagnosis of hemophagocytic lymphohistiocytosis (HLH).
Special thanks to my supervisor Dr. Hripsime Apresyan, for her guidance and mentorship.

Key take-home messages include:
1. Visceral leishmaniasis (VL) is a parasitic vector-borne disease endemic in Armenia.

2. Rarely VL can cause secondary HLH, a life-threatening condition requiring early recognition and treatment.

3. Continuation of liposomal amphotericin B treatment beyond the standard total dose of 21 mg/kg is warranted in cases of disease relapse, treatment failure associated with HLH, and immunosuppression.

I want to extend our gratitude to the pediatric infectious disease team and the entire medical staff of Muratsan University Hospital Complex. I appreciate their invaluable contributions to diagnosis and treatment, as well as their compassionate care for our patients.”

Source: Mark Grigoryan/LinkedIn

About OncoDaily 

OncoDaily was founded in 2023. It is a US-based oncology media platform, which features the latest news, insights, and patient stories from the world of oncology. Within a short period of time it became one of the leading oncology media platforms globally.

OncoDaily gathers content from various sources, including social media posts from renowned oncologists from all over the world, news from oncology societies and cancer centers, patient and survivor stories, and career-related information for professionals.

The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is “Cancer doesn’t take a day off – neither do we”.